A recent study performed snRNA-seq on 482,472 nuclei from non-demented control brains and AD brain regions containing only Aβ plaques or both Aβ plaques and tau pathology (Gerrits et al., 2021). This evidence concerns the gene MAPT and Alzheimer disease.